Allergan Aesthetics releases small skin study on GLP-1 medication users

Go back to Allergan Aesthetics releases small skin study on GLP-1 medication users

Allergan Aesthetics Presents New Clinical Data Evaluating Skin Quality Improvements in Individuals Taking Medical Weight Loss Medications

September 17, 2026 8:00 AM EDT

Two studies evaluating targeted skincare and dermabrasion approaches will be presented at the 2026 Science of Skin Summit

IRVINE, Calif., Sept. 17, 2026 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company (NYSE: ABBV), today announced results from two single-center clinical studies evaluating targeted skincare regimens alone and in combination with DiamondGlow® dermabrasion treatments in individuals taking medical weight loss (MWL)... More